FDA inspection
Nowcos Co., Ltd.: FDA inspection ending Aug 4, 2017
FDA inspection 1020295 · Official Action Indicated (OAI) · Sejong
Key facts
| Inspection ID | 1020295 |
|---|---|
| Firm | Nowcos Co., Ltd. |
| FEI number | 3009968674 |
| Address | 220 Sandan-Gil, Jeonui-Myeon |
| City | Sejong |
| Country | Korea (the Republic of) |
| Fiscal year | 2017 |
| Inspection end date | Aug 4, 2017 |
| Classification | Official Action Indicated (OAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
| Warning letter | 541054 |
At a glance
- 10–99 Citations
- 1–9 Posted citations
- Yes Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data